Drugs Target Ligand Cancer Approval year
Cabergoline Dopamine receptor D1 (DRD1) Small molecule Neuroendocrine tumors, pituitary tumors 1996
Lanreotide Somatostatin receptor (SSTR) Hormone Pancreatic cancer 2007
Degarelix Gonadotropin releasing factor hormone receptor (GnRH) Hormone Prostate cancer 2008
Plerixafor C-X-C chemokine receptor 4 (CXCR4) Small molecule Multiple myeloma 2008
Vismodegib (Erivedge) Smoothened receptor (SMO) Small molecule Locally advanced, and metastatic basal cell carcinoma 2012
Raloxifene Estrogen receptor (ER) Small molecule Breast cancer 2014
Sonidegib (Odomzo) Smoothened receptor (SMO) Small molecule Locally advanced, and metastatic basal cell carcinoma 2015
Mogamulizumab C–C Chemokine receptor 4 (CCR4) Antibody T cell lymphoma 2018